Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)

SHA:603538 Revenue

Ningbo Menovo Pharmaceutical had revenue of 439.46M CNY in the quarter ending September 30, 2025, with 28.80% growth. This brings the company's revenue in the last twelve months to 1.54B, up 24.54% year-over-year. In the year 2024, Ningbo Menovo Pharmaceutical had annual revenue of 1.37B with 12.85% growth.

• Revenue (ttm): 1.54B
• Revenue Growth: +24.54%
• P/S Ratio: 2.96
• Revenue / Employee: 623.21K
• Employees: 2,404
• Market Cap: 4.56B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.37B	156.36M	12.85%
Dec 31, 2023	1.22B	-240.48M	-16.51%
Dec 31, 2022	1.46B	198.83M	15.80%
Dec 31, 2021	1.26B	64.77M	5.43%
Dec 31, 2020	1.19B	13.17M	1.12%